US$ 20.85
drugs glp 1 Popular GLP-1 medications may have health benefits that extend beyond weight loss and blood sugar control, a new study finds Chart: 1 in 8 Americans
Description
10.1038/s41591-021-01391-w

This pattern continued when assessing the risk for atrial fibrillation, as the GLP-1 group had a significantly decreased risk for this outcome vs

Furthermore, systematic clinical evidence regarding the long-term impact of GLP-1RAs on cancer risk is lacking, creating challenges for assessing the long-term safety of these treatments
Tell your healthcare provider right away if you have nausea, vomiting, or diarrhea that does not go away severe stomach problems

Comorbidities: Type 2 diabetes: Both are FDA-approved for diabetes (tirzepatide as Mounjaro, semaglutide as Ozempic) Cardiovascular disease: Semaglutide has the cardiovascular outcomes data Sleep apnea: Tirzepatide has shown benefits Injection frequency: Both are once-weekly
